Forbes January 4, 2021
2020 was an incredibly paradoxical year for those of us in biotech: the striking dichotomy of simultaneously experiencing agonizing tragedy alongside buoyant optimism.
It was truly a horrifically tragic year for humanity, and for America in particular. As everyone knows, the worst viral pandemic in a century has ravaged the country and taken over 350,000 American lives. Sadly, the desensitization of large parts of society to death and suffering is also alarming, including for those of us in biotech who are working to prolong life, and improve its quality, through better health. We’re witnessing a death rate comparable to the 9/11 disaster every day, and that event mobilized the entire nation for a decade. Today, while valiant efforts are being...
Today's Sponsors
Today's Sponsor